Although methotrexate is the most widely used medication for psoriatic arthritis (PsA), evidence for its effectiveness is scant. The recent MIPA trial failed to show disease-modifying effects. Was this outcome due to true inefficacy, or to trial issues? Data on symptom-modulating and disease-modifying effects of methotrexate in PsA are explored.
机构:
AARHUS UNIV,AARHUS KOMMUNE HOSP,DEPT PHYS MED & RHEUMATOL,DK-8000 AARHUS C,DENMARKAARHUS UNIV,AARHUS KOMMUNE HOSP,DEPT PHYS MED & RHEUMATOL,DK-8000 AARHUS C,DENMARK
KRAGBALLE, K
ZACHARIAE, E
论文数: 0引用数: 0
h-index: 0
机构:
AARHUS UNIV,AARHUS KOMMUNE HOSP,DEPT PHYS MED & RHEUMATOL,DK-8000 AARHUS C,DENMARKAARHUS UNIV,AARHUS KOMMUNE HOSP,DEPT PHYS MED & RHEUMATOL,DK-8000 AARHUS C,DENMARK
ZACHARIAE, E
ZACHARIAE, H
论文数: 0引用数: 0
h-index: 0
机构:
AARHUS UNIV,AARHUS KOMMUNE HOSP,DEPT PHYS MED & RHEUMATOL,DK-8000 AARHUS C,DENMARKAARHUS UNIV,AARHUS KOMMUNE HOSP,DEPT PHYS MED & RHEUMATOL,DK-8000 AARHUS C,DENMARK